China · Delayed Price · Currency is CNY Novogene Statistics
Total Valuation
Novogene has a market cap or net worth of CNY 6.19 billion. The enterprise value is 4.75 billion.
| Market Cap | 6.19B |
| Enterprise Value | 4.75B |
Important Dates
The next estimated earnings date is Wednesday, April 15, 2026.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | Jun 10, 2025 |
Share Statistics
Novogene has 405.06 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 405.06M |
| Shares Outstanding | 405.06M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -6.07% |
| Owned by Insiders (%) | 53.05% |
| Owned by Institutions (%) | 9.17% |
| Float | 133.05M |
Valuation Ratios
The trailing PE ratio is 35.47 and the forward PE ratio is 31.61.
| PE Ratio | 35.47 |
| Forward PE | 31.61 |
| PS Ratio | 2.85 |
| PB Ratio | 2.36 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | 42.85 |
| P/OCF Ratio | 23.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.12, with an EV/FCF ratio of 32.91.
| EV / Earnings | 27.13 |
| EV / Sales | 2.19 |
| EV / EBITDA | 15.12 |
| EV / EBIT | 30.16 |
| EV / FCF | 32.91 |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.61 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.46 |
| Interest Coverage | 97.20 |
Financial Efficiency
Return on equity (ROE) is 7.08% and return on invested capital (ROIC) is 12.28%.
| Return on Equity (ROE) | 7.08% |
| Return on Assets (ROA) | 2.74% |
| Return on Invested Capital (ROIC) | 12.28% |
| Return on Capital Employed (ROCE) | 5.91% |
| Weighted Average Cost of Capital (WACC) | 8.79% |
| Revenue Per Employee | 986,773 |
| Profits Per Employee | 79,569 |
| Employee Count | 2,190 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 5.53 |
Taxes
In the past 12 months, Novogene has paid 17.85 million in taxes.
| Income Tax | 17.85M |
| Effective Tax Rate | 9.04% |
Stock Price Statistics
The stock price has increased by +5.02% in the last 52 weeks. The beta is 0.84, so Novogene's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +5.02% |
| 50-Day Moving Average | 14.64 |
| 200-Day Moving Average | 14.79 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 6,935,917 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novogene had revenue of CNY 2.17 billion and earned 175.21 million in profits. Earnings per share was 0.43.
| Revenue | 2.17B |
| Gross Profit | 932.20M |
| Operating Income | 157.63M |
| Pretax Income | 197.45M |
| Net Income | 175.21M |
| EBITDA | 294.04M |
| EBIT | 157.63M |
| Earnings Per Share (EPS) | 0.43 |
Balance Sheet
The company has 1.53 billion in cash and 66.17 million in debt, with a net cash position of 1.46 billion or 3.61 per share.
| Cash & Cash Equivalents | 1.53B |
| Total Debt | 66.17M |
| Net Cash | 1.46B |
| Net Cash Per Share | 3.61 |
| Equity (Book Value) | 2.62B |
| Book Value Per Share | 6.41 |
| Working Capital | 1.67B |
Cash Flow
In the last 12 months, operating cash flow was 259.82 million and capital expenditures -115.38 million, giving a free cash flow of 144.44 million.
| Operating Cash Flow | 259.82M |
| Capital Expenditures | -115.38M |
| Free Cash Flow | 144.44M |
| FCF Per Share | 0.36 |
Margins
Gross margin is 42.90%, with operating and profit margins of 7.25% and 8.06%.
| Gross Margin | 42.90% |
| Operating Margin | 7.25% |
| Pretax Margin | 9.09% |
| Profit Margin | 8.06% |
| EBITDA Margin | 13.53% |
| EBIT Margin | 7.25% |
| FCF Margin | 6.65% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.33%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.33% |
| Dividend Growth (YoY) | 5.26% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 11.56% |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.43% |
| Earnings Yield | 2.83% |
| FCF Yield | 2.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novogene has an Altman Z-Score of 4.95 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.95 |
| Piotroski F-Score | 6 |